Revelio Therapeutics is focused on advancing novel tumor-specific biologics for the treatment of cancer.

Sectors
Healthcare
Biopharma
First Invested
2022
Early
Company Status
Private
Board Members
Ali Behbahani, MD
Associated Team
James Buxton, MD
Website
Revelio
Revelio